CDMO
Cell Therapy
Gene Therapy
In the complex and rapidly evolving landscape of cell and gene therapy, selecting a Contract Development and Manufacturing Organization (CDMO) is one of the most consequential relationships an innovator will establish. No two drug manufacturing journeys are the same; the path from bench to bedside may contain unforeseen scientific nuances, regulatory hurdles, or operational constraints. Consequently, the task of identifying an honest, reliable partner is of the utmost importance.
